BioNexus Gene Lab (BGLC) Interest & Investment Income (2024 - 2026)

BioNexus Gene Lab has disclosed Interest & Investment Income across 3 years of filings, most recently posting $17179.0 for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $17179.0, down 27.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $77499.0 (down 45.51% YoY), and the FY2025 annual result was $83888.0, down 43.18% from the prior year.
• Interest & Investment Income came in at $17179.0 for Q1 2026 at BioNexus Gene Lab, up from $9774.0 in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $49739.0 in Q2 2024 to a low of $9774.0 in Q4 2025.
• The 3-year median for Interest & Investment Income is $28983.0 (2024), against an average of $27634.2.
• Peak annual rise in Interest & Investment Income reached 18.68% in 2025, while the deepest fall reached 71.17% in 2025.
• BioNexus Gene Lab's Interest & Investment Income stood at $33897.0 in 2024, then tumbled by 71.17% to $9774.0 in 2025, then soared by 75.76% to $17179.0 in 2026.
• The last three Interest & Investment Income figures came in at $17179.0 (Q1 2026), $9774.0 (Q4 2025), and $20778.0 (Q3 2025), per Business Quant data.